vs
Side-by-side financial comparison of INTRUSION INC (INTZ) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Q32 Bio Inc. is the larger business by last-quarter revenue ($1.9M vs $1.5M, roughly 1.3× INTRUSION INC). Q32 Bio Inc. runs the higher net margin — 2991.2% vs -190.7%, a 3181.9% gap on every dollar of revenue.
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
INTZ vs QTTB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $1.9M |
| Net Profit | $-2.8M | $57.7M |
| Gross Margin | 74.3% | — |
| Operating Margin | -192.4% | — |
| Net Margin | -190.7% | 2991.2% |
| Revenue YoY | -11.6% | — |
| Net Profit YoY | -44.4% | 506.9% |
| EPS (diluted) | $-0.15 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $1.9M | ||
| Q3 25 | $2.0M | $-220.0K | ||
| Q2 25 | $1.9M | $-284.0K | ||
| Q1 25 | $1.8M | $-371.0K | ||
| Q4 24 | $1.7M | $0 | ||
| Q3 24 | $1.5M | $0 | ||
| Q2 24 | $1.5M | $0 | ||
| Q1 24 | $1.1M | $0 |
| Q4 25 | $-2.8M | $57.7M | ||
| Q3 25 | $-2.1M | $-7.4M | ||
| Q2 25 | $-2.0M | $-9.5M | ||
| Q1 25 | $-2.1M | $-11.0M | ||
| Q4 24 | $-2.0M | $-14.2M | ||
| Q3 24 | $-2.0M | $-17.6M | ||
| Q2 24 | $-2.1M | $-17.0M | ||
| Q1 24 | $-1.7M | $1.0M |
| Q4 25 | 74.3% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 77.1% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 80.0% | — |
| Q4 25 | -192.4% | — | ||
| Q3 25 | -108.6% | 3444.1% | ||
| Q2 25 | -111.4% | 3229.2% | ||
| Q1 25 | -117.9% | 3296.0% | ||
| Q4 24 | -113.5% | — | ||
| Q3 24 | -135.5% | — | ||
| Q2 24 | -139.2% | — | ||
| Q1 24 | -218.6% | — |
| Q4 25 | -190.7% | 2991.2% | ||
| Q3 25 | -106.5% | 3358.6% | ||
| Q2 25 | -109.0% | 3341.2% | ||
| Q1 25 | -118.2% | 2973.3% | ||
| Q4 24 | -116.8% | — | ||
| Q3 24 | -136.3% | — | ||
| Q2 24 | -141.6% | — | ||
| Q1 24 | -151.7% | — |
| Q4 25 | $-0.15 | $4.70 | ||
| Q3 25 | $-0.10 | $-0.60 | ||
| Q2 25 | $-0.10 | $-0.78 | ||
| Q1 25 | $-0.11 | $-0.90 | ||
| Q4 24 | $0.19 | $2.63 | ||
| Q3 24 | $-0.35 | $-1.46 | ||
| Q2 24 | $-0.53 | $-1.42 | ||
| Q1 24 | $-0.94 | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $42.0M |
| Total Assets | $10.4M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $48.3M | ||
| Q3 25 | $4.5M | $49.0M | ||
| Q2 25 | $8.4M | $54.8M | ||
| Q1 25 | $10.7M | $65.5M | ||
| Q4 24 | $4.9M | $78.0M | ||
| Q3 24 | $1.1M | $89.1M | ||
| Q2 24 | $1.5M | $97.7M | ||
| Q1 24 | $122.0K | $115.5M |
| Q4 25 | $7.3M | $42.0M | ||
| Q3 25 | $9.8M | $-18.4M | ||
| Q2 25 | $11.6M | $-12.2M | ||
| Q1 25 | $13.4M | $-4.0M | ||
| Q4 24 | $6.3M | $5.7M | ||
| Q3 24 | $2.6M | $18.3M | ||
| Q2 24 | $2.9M | $33.5M | ||
| Q1 24 | $-1.2M | $48.8M |
| Q4 25 | $10.4M | $61.8M | ||
| Q3 25 | $13.7M | $57.8M | ||
| Q2 25 | $16.4M | $66.1M | ||
| Q1 25 | $18.0M | $79.1M | ||
| Q4 24 | $11.5M | $92.3M | ||
| Q3 24 | $7.4M | $104.5M | ||
| Q2 24 | $7.5M | $124.2M | ||
| Q1 24 | $5.7M | $152.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-531.0K | $-6.2M |
| Free Cash FlowOCF − Capex | $-549.0K | — |
| FCF MarginFCF / Revenue | -37.1% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | — | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-531.0K | $-6.2M | ||
| Q3 25 | $-3.0M | $-4.2M | ||
| Q2 25 | $-1.6M | $-10.7M | ||
| Q1 25 | $-1.7M | $-12.5M | ||
| Q4 24 | $-178.0K | $-11.4M | ||
| Q3 24 | $-2.1M | $-19.5M | ||
| Q2 24 | $-2.9M | $-22.2M | ||
| Q1 24 | $-1.1M | $-14.6M |
| Q4 25 | $-549.0K | — | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $-1.9M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-645.0K | $-11.4M | ||
| Q3 24 | $-2.1M | $-19.6M | ||
| Q2 24 | $-3.0M | $-22.2M | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | -37.1% | — | ||
| Q3 25 | -153.2% | — | ||
| Q2 25 | -101.1% | — | ||
| Q1 25 | -117.3% | — | ||
| Q4 24 | -38.5% | — | ||
| Q3 24 | -140.4% | — | ||
| Q2 24 | -202.3% | — | ||
| Q1 24 | -104.2% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 5.7% | — |
| Q4 25 | — | -0.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
